MAPT and Alzheimer disease: In older AD mice, mitoQ treatment improved memory retention, prevented synaptic loss, reduced oxidative stress, reduced astro- and micro-gliosis, and reduced tau and Aβ accumulation, caspase activation, and tau hyperphosphorylation [180].